Subjective, behavioral and neurobiological effects of cannabis and cannabinoids in social anxiety

The Influence of the COVID-19 Pandemic on Social Anxiety: A Systematic Review

(2023) Reuben Kindred et al.   International Journal of Environmental Research and Public Health

Cannabis use and social anxiety in young adulthood: A meta-analysis

(2022) Alanna Single et al.   ADDICTIVE BEHAVIORS

Cannabidiol enhancement of exposure therapy in treatment refractory patients with social anxiety disorder and panic disorder with agoraphobia: A randomised controlled trial

(2022) Caroline MB Kwee et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Social Anxiety and Suicidality in Youth: A Systematic Review and Meta-analysis

(2022) Eleanor Leigh et al.   Research on Child and Adolescent Psychopathology

Altered relationship between cortisol response to social stress and mediotemporal function during fear processing in people at clinical high risk for psychosis: a preliminary report

(2021) Cathy Davies et al.   EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE

Effects of acute cannabidiol administration on anxiety and tremors induced by a Simulated Public Speaking Test in patients with Parkinson’s disease

(2020) Stephanie Martins de Faria et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Effects of short-term cannabidiol treatment on response to social stress in subjects at clinical high risk of developing psychosis

(2020) E. Appiah-Kusi et al.   PSYCHOPHARMACOLOGY

Change over time in adolescent smoking, cannabis use and their association: findings from the School Health Research Network in Wales

(2020) N Page et al.   JOURNAL OF PUBLIC HEALTH

Cannabis, a cause for anxiety? A critical appraisal of the anxiogenic and anxiolytic properties

(2020) Lara Sharpe et al.   Journal of Translational Medicine

A single dose of cannabidiol modulates medial temporal and striatal function during fear processing in people at clinical high risk for psychosis

(2020) Cathy Davies et al.   Translational Psychiatry

Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options

(2020) Amir Garakani et al.   Frontiers in Psychiatry

Cannabinoids, interoception, and anxiety

(2019) Allyson K. Andrade et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

Treatment adequacy for social anxiety disorder in primary care patients

(2018) Alexandra Chapdelaine et al.   PLoS One

Cannabidiol presents an inverted U-shaped dose-response curve in a simulated public speaking test

(2018) Ila M. Linares et al.   REVISTA BRASILEIRA DE PSIQUIATRIA

Inverted U-Shaped Dose-Response Curve of the Anxiolytic Effect of Cannabidiol during Public Speaking in Real Life

(2017) Antonio W. Zuardi et al.   Frontiers in Pharmacology

Acute effects of delta-9-tetrahydrocannabinol, cannabidiol and their combination on facial emotion recognition: A randomised, double-blind, placebo-controlled study in cannabis users

(2015) Chandni Hindocha et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Cannabinoid Modulation of Amygdala Subregion Functional Connectivity to Social Signals of Threat

(2015) S. M. Gorka et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

The endocannabinoid system and emotional processing: A pharmacological fMRI study with ∆9-tetrahydrocannabinol

(2013) Matthijs G. Bossong et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Human experimental anxiety: actual public speaking induces more intense physiological responses than simulated public speaking

(2013) Antonio Waldo Zuardi et al.   REVISTA BRASILEIRA DE PSIQUIATRIA

Attenuated cortisol response to acute psychosocial stress in individuals at ultra-high risk for psychosis

(2013) Marita Pruessner et al.   SCHIZOPHRENIA RESEARCH

Effects of delta-9-tetrahydrocannabinol on evaluation of emotional images

(2012) Michael E Ballard et al.   JOURNAL OF PSYCHOPHARMACOLOGY

The impact of comorbid cannabis use disorders on the clinical presentation of social anxiety disorder

(2011) Elizabeth Tepe et al.   JOURNAL OF PSYCHIATRIC RESEARCH

Cannabidiol Reduces the Anxiety Induced by Simulated Public Speaking in Treatment-Naïve Social Phobia Patients

(2011) Mateus M Bergamaschi et al.   NEUROPSYCHOPHARMACOLOGY

Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report

(2010) José Alexandre S Crippa et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Distinct Effects of Δ9-Tetrahydrocannabinol and Cannabidiol on Neural Activation During Emotional Processing

(2009) Paolo Fusar-Poli et al.   ARCHIVES OF GENERAL PSYCHIATRY

Social anxiety disorder women easily recognize fearfull, sad and happy faces: The influence of gender

(2009) Kátia C. Arrais et al.   JOURNAL OF PSYCHIATRIC RESEARCH

Opposite Effects of Δ-9-Tetrahydrocannabinol and Cannabidiol on Human Brain Function and Psychopathology

(2009) Sagnik Bhattacharyya et al.   NEUROPSYCHOPHARMACOLOGY

On-line preconcentration of copper as its pyrocatechol violet complex on Chromosorb 105 for flame atomic absorption spectrometric determinations

(2008) Berrin Buke et al.   JOURNAL OF HAZARDOUS MATERIALS

Cannabinoid Modulation of Amygdala Reactivity to Social Signals of Threat in Humans

(2008) K. L. Phan et al.   JOURNAL OF NEUROSCIENCE

Social anxiety disorder

(2008) Murray B Stein et al.   LANCET